I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 20 studies | 33% ± 16% | |
| myeloid cell | 3 studies | 26% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 20 studies | 33% ± 16% | |
| myeloid cell | 3 studies | 26% ± 2% |
Insufficient scRNA-seq data for expression of LILRB5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 2267.45 | 257 / 258 | 73% | 16.69 | 169 / 230 |
| lung | 97% | 1330.77 | 563 / 578 | 73% | 2.79 | 845 / 1155 |
| intestine | 98% | 1327.94 | 948 / 966 | 47% | 1.25 | 249 / 527 |
| bladder | 95% | 877.67 | 20 / 21 | 49% | 2.11 | 245 / 504 |
| liver | 75% | 654.92 | 170 / 226 | 67% | 2.04 | 274 / 406 |
| breast | 88% | 1716.56 | 405 / 459 | 53% | 1.47 | 589 / 1118 |
| stomach | 65% | 458.82 | 235 / 359 | 55% | 1.46 | 158 / 286 |
| skin | 42% | 309.52 | 768 / 1809 | 76% | 3.56 | 359 / 472 |
| esophagus | 73% | 923.41 | 1050 / 1445 | 40% | 1.18 | 74 / 183 |
| kidney | 44% | 278.81 | 39 / 89 | 63% | 2.64 | 565 / 901 |
| spleen | 100% | 11593.81 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 4192.59 | 1198 / 1204 | 0% | 0 | 0 / 0 |
| thymus | 61% | 350.42 | 397 / 653 | 38% | 1.84 | 231 / 605 |
| lymph node | 0% | 0 | 0 / 0 | 86% | 3.66 | 25 / 29 |
| ovary | 47% | 267.08 | 84 / 180 | 31% | 0.68 | 135 / 430 |
| heart | 76% | 662.77 | 657 / 861 | 0% | 0 | 0 / 0 |
| uterus | 38% | 205.60 | 64 / 170 | 37% | 1.01 | 172 / 459 |
| eye | 0% | 0 | 0 / 0 | 70% | 2.57 | 56 / 80 |
| blood vessel | 66% | 685.33 | 887 / 1335 | 0% | 0 | 0 / 0 |
| pancreas | 9% | 27.79 | 29 / 328 | 57% | 1.84 | 101 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 49% | 1.50 | 22 / 45 |
| muscle | 40% | 193.19 | 319 / 803 | 0% | 0 | 0 / 0 |
| prostate | 18% | 95.33 | 43 / 245 | 17% | 0.26 | 84 / 502 |
| brain | 1% | 4.67 | 31 / 2642 | 24% | 0.76 | 171 / 705 |
| peripheral blood | 7% | 33.48 | 61 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0002250 | Biological process | adaptive immune response |
| GO_0002764 | Biological process | immune response-regulating signaling pathway |
| GO_0006952 | Biological process | defense response |
| GO_0007166 | Biological process | cell surface receptor signaling pathway |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0004888 | Molecular function | transmembrane signaling receptor activity |
| Gene name | LILRB5 |
| Protein name | Leukocyte immunoglobulin-like receptor subfamily B member 5 (CD85 antigen-like family member C) (Leukocyte immunoglobulin-like receptor 8) (LIR-8) (CD antigen CD85c) Leukocyte immunoglobulin-like receptor subfamily B member 5 |
| Synonyms | LIR8 |
| Description | FUNCTION: May act as receptor for class I MHC antigens. |
| Accessions | A0A0G2JMR1 A0A0G2JNY7 ENST00000614807.4 ENST00000316219.9 [O75023-1] ENST00000616805.4 ENST00000610568.4 ENST00000614318.1 ENST00000619608.4 ENST00000622596.4 A0A0G2JNF6 A0A0G2JPM8 O75023 A0A0G2JNR0 ENST00000449561.3 [O75023-3] A0A0G2JNP3 ENST00000622648.4 ENST00000620244.4 ENST00000620714.4 ENST00000614645.1 ENST00000621867.4 A0A0G2JMX5 ENST00000617355.4 ENST00000616618.4 ENST00000615267.4 ENST00000621221.4 ENST00000618355.1 ENST00000615429.1 ENST00000610764.4 ENST00000621193.4 ENST00000345866.10 [O75023-2] ENST00000615837.4 |
